---
schema_version: "secwatch.filing_event.v1"
accession: "0001935979-24-000002"
form_type: "8-K"
ticker: "BHVN"
cik: "0001935979"
company_name: "Biohaven Ltd."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:38:15.709749+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Biohaven presents at J.P. Morgan Healthcare Conference; pipeline updates expected

## Summary
- CEO Vlad Coric presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
- Presentation likely covers clinical trial progress for OCD and other pipeline programs.
- No specific financial or clinical data disclosed in the exhibit text provided.
- Form 8-K furnishes the presentation as Exhibit 99.1 under Regulation FD.

## SEC filing metadata
- accession: 0001935979-24-000002
- form_type: 8-K
- ticker: BHVN
- cik: 0001935979
- company_name: Biohaven Ltd.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1935979/000193597924000002/0001935979-24-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1935979/000193597924000002/bhvn-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001935979-24-000002
- JSON: https://secwatch.observer/filing/0001935979-24-000002.json
- Plain text: https://secwatch.observer/filing/0001935979-24-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.